Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2020-06-04 (5 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PERRIGNY (39570), Jura
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
LA PHARMACIE DE PERRIGNY : revenue, balance sheet and financial ratios
LA PHARMACIE DE PERRIGNY is a French company
founded 5 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PERRIGNY (39570),
this company of category PME
shows in 2025 a net income positive of 64 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - LA PHARMACIE DE PERRIGNY (SIREN 885365593)
Indicator
2025
2024
2023
Revenue
N/C
N/C
N/C
Net income
64 235 €
108 652 €
110 710 €
EBITDA
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
Revenue and income statement
In 2025, LA PHARMACIE DE PERRIGNY generates positive net income of 64 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2023-2025: 111 k€ -> 64 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
64 235 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 49%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 58%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
48.507%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
58.224%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution LA PHARMACIE DE PERRIGNY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2023
2024
2025
Debt ratio
125.95
77.707
48.507
Financial autonomy
39.874
49.834
58.224
Repayment capacity
None
None
None
Cash flow / Revenue
None%
None%
None%
Sector positioning
Debt ratio
48.512025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good-15 pts over 3 years
In 2025, the debt ratio of LA PHARMACIE DE PERRIGNY (48.51) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
58.22%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good+17 pts over 3 years
In 2025, the financial autonomy of LA PHARMACIE DE PERRIGNY (58.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 274.22. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
274.216
Liquidity indicators evolution LA PHARMACIE DE PERRIGNY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2023
2024
2025
Liquidity ratio
382.156
346.925
274.216
Interest coverage
None
None
None
Sector positioning
Liquidity ratio
274.222025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excellent
In 2025, the liquidity ratio of LA PHARMACIE DE PERRIGNY (274.22) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of LA PHARMACIE DE PERRIGNY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of LA PHARMACIE DE PERRIGNY is estimated at
1 020 380 €
(range 692 435€ - 1 601 117€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
692k€1020k€1601k€
1 020 380 €Range: 692 435€ - 1 601 117€
NAF 5 année 2025
Valuation method used
Net Income Multiple
64 235 €
×
15.9x
=1 020 381 €
Range: 692 435€ - 1 601 118€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare LA PHARMACIE DE PERRIGNY with other companies in the same sector:
Frequently asked questions about LA PHARMACIE DE PERRIGNY
What is the revenue of LA PHARMACIE DE PERRIGNY ?
The revenue of LA PHARMACIE DE PERRIGNY is not publicly disclosed (confidential accounts filed with INPI).
Is LA PHARMACIE DE PERRIGNY profitable?
Yes, LA PHARMACIE DE PERRIGNY generated a net profit of 64 k€ in 2025.
Where is the headquarters of LA PHARMACIE DE PERRIGNY ?
The headquarters of LA PHARMACIE DE PERRIGNY is located in PERRIGNY (39570), in the department Jura.
Where to find the tax return of LA PHARMACIE DE PERRIGNY ?
The tax return of LA PHARMACIE DE PERRIGNY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does LA PHARMACIE DE PERRIGNY operate?
LA PHARMACIE DE PERRIGNY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart